Everolimus for advanced pancreatic neuroendocrine tumors - Yao, JC; Shah, MH; Ito, T; RAD001 in Advanced Neuroendocrine Tumors; Third Trial (RADIANT-3) Study Group (N Engl J Med, 2011)
et al.